- Home
- CKPT vs BCAB Comparison
CKPT vs BCAB Comparison
Compare CKPT & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CKPT
- BCAB
- Stock Information
- Founded
- CKPT 2014
- BCAB 2007
- Country
- CKPT United States
- BCAB United States
- Employees
- CKPT N/A
- BCAB N/A
- Industry
- CKPT Biotechnology: Pharmaceutical Preparations
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- CKPT Health Care
- BCAB Health Care
- Exchange
- CKPT Nasdaq
- BCAB Nasdaq
- Market Cap
- CKPT N/A
- BCAB 96.2M
- IPO Year
- CKPT 2017
- BCAB 2020
- Fundamental
- Price
- CKPT $3.77
- BCAB $2.08
- Analyst Decision
- CKPT Strong Buy
- BCAB Strong Buy
- Analyst Count
- CKPT 2
- BCAB 2
- Target Price
- CKPT $12.00
- BCAB $6.00
- AVG Volume (30 Days)
- CKPT 946.5K
- BCAB 1.6M
- Earning Date
- CKPT 11-11-2024
- BCAB 11-08-2024
- Dividend Yield
- CKPT N/A
- BCAB N/A
- EPS Growth
- CKPT N/A
- BCAB N/A
- EPS
- CKPT N/A
- BCAB N/A
- Revenue
- CKPT $78,000.00
- BCAB N/A
- Revenue This Year
- CKPT N/A
- BCAB N/A
- Revenue Next Year
- CKPT $151,162.55
- BCAB N/A
- P/E Ratio
- CKPT N/A
- BCAB N/A
- Revenue Growth
- CKPT N/A
- BCAB N/A
- 52 Week Low
- CKPT $1.36
- BCAB $1.14
- 52 Week High
- CKPT $3.95
- BCAB $4.02
- Technical
- Relative Strength Index (RSI)
- CKPT 84.67
- BCAB 55.80
- Support Level
- CKPT $2.37
- BCAB $1.87
- Resistance Level
- CKPT $2.54
- BCAB $2.13
- Average True Range (ATR)
- CKPT 0.27
- BCAB 0.12
- MACD
- CKPT 0.10
- BCAB 0.00
- Stochastic Oscillator
- CKPT 88.60
- BCAB 68.90
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.